Recalls / —
—#92510
Product
Hospira brand Symbiq Two-Channel Infuser; List Number: 16027; Distributed by: Hospira, Inc. Morgan Hill, CA and Manufactured by: Hospira Inc, La Aurora, Heredia, Costa Rica. Intended for the delivery of fluids, solutions, drugs, agents, nutritionals, electrolytes, blood and blood products via parenteral, enteral, intravenous, intra-arterial, subcutaneous, epidural or irrigation routes of administration.
- FDA product code
- FRN — Pump, Infusion
- Device class
- Class 2
- Medical specialty
- General Hospital
- 510(k) numbers
- K041550
- Affected lot / code info
- All units including List Number Configurations: 16027-04-01/03/04,51/52,53/54, 79/80,81/82,83/84,87/88 and 89/90; 16027-27-89/90; 16027-13-25/26,53/54.
Why it was recalled
Hospira has received numerous customer complaints of the Symbiq infusion pump's failure to detect air-in-line conditions during operation.
Root cause (FDA determination)
Device Design
Action the firm took
Hospira issued a "Urgent: Medical Device Recall Notification" dated June 11, 2010 to update a previously issued Clinical Bulletin. Customers were informed of the issue and instructed on proper mitigation steps to further avoid the issue associated with the affected product. Consignees were asked to complete and return the Reply Form. For further information, contact Hospira Technical Support Operations at 1-800-332-4002, 6AM to 4PM PST, Monday through Friday.
Recalling firm
- Firm
- Hospira Inc
- Address
- 755 Jarvis Dr, Morgan Hill, California 95037-2810
Distribution
- Distribution pattern
- Worldwide Distribution -- United States (AL, CA, CO, CT, DE, FL, GA, HI, IA, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, NC, ND, NE, NH, NJ, NY, OH, OK, PA, SC, SD, TN, TX, VA and WA), and Australia, Canada, Colombia, Costa Rica, Malaysia, Mexico, Puerto Rico, Singapore and United Arab Emirates.
Timeline
- Recall initiated
- 2010-04-09
- Posted by FDA
- 2010-07-02
- Terminated
- 2013-12-03
- Status
- —
Source: openFDA Device Recall endpoint. Recall record ID #92510. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.